Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis: comment

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|3|485-486

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.3, 2015-03, pp. : 485-486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement

By  

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (ELECTRONIC), Vol. 74, Iss. 4, 2015-10 ,pp. : 345-356

John Wiley & Sons Inc

Access to resources Recommend Favorite

Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement

By  

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (ELECTRONIC), Vol. 1046-7408, Iss. 4, 2015-10 ,pp. : 345-356

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atypical Hemolytic Uremic Syndrome: Update on the Complement System and What Is New

By  

Nephron Clin Pract, Vol. 114, Iss. 4, 2010-01 ,pp. : c219-c235

Karger

Access to resources Recommend Favorite

Autoimmune‐type atypical hemolytic uremic syndrome treated with eculizumab as first‐line therapy

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 2, 2015-04 ,pp. : 313-317

John Wiley & Sons Inc

Access to resources Recommend Favorite

Atypical hemolytic uremic syndrome: Korean pediatric series

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 3, 2015-06 ,pp. : 431-438

John Wiley & Sons Inc

Access to resources Recommend Favorite